Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
ORCHESTRA BIOMED HLD

OBIO

$4.13Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$249M
MVM
+$2.3M
TD Variance
2.000

Every news event mapped to its market reaction — 52 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-01-27-31.6%M&ASeeking AlphaHealth Sciences Acquisition up 15% as Roderick Wong buys $18.1M stock
2023-01-25+29.4%M&ASeeking AlphaSPAC Health Sciences II shareholders approve Orchestra BioMed merger
2025-03-31-27.3%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$1.66 in-line, revenue of $2.63M misses by $0.57M
2023-07-27-24.1%newsCoinCodexOrchestra BioMed Holdings, Inc. (OBIO) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2024-01-19+22.7%newsSeeking AlphaJefferies starts Orchestra BioMed at buy, cites lead program opportunities
2023-06-26-22.2%newsSeeking AlphaOrchestra BioMed to join 3 Russell indexes
2025-07-31-19.8%expansionSeeking AlphaOrchestra BioMed launches public offering; shares down 16%
2023-11-14+15.7%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.38 beats by $0.04, revenue of $0.42M
2023-10-10-15.5%newsSeeking AlphaOrchestra BioMed files prospectus for issuance of up to 1.93M shares
2023-06-07-13.7%executiveSeeking AlphaOrchestra BioMed appoints Andrew Taylor as CFO, succeeding Kaswan
2025-08-01-12.3%newsSeeking AlphaOrchestra BioMed announces pricing of $40 million public offering
2024-05-15-12.2%earningsSeeking AlphaOrchestra BioMed reports Q1 results
2024-08-13-11.3%earningsSeeking AlphaOrchestra BioMed reports Q2 results
2023-12-02+7.9%analystTradingViewOBIO Forecast — Price Target — Prediction for 2027 - TradingView
2026-03-27-7.3%newsStock TitanOrchestra BioMed (NASDAQ: OBIO) insider reports RSU tax withholding event - Stock Titan
2026-03-27-7.3%newsStock TitanOrchestra BioMed (OBIO) insider withholds 32,438 RSU shares for tax - Stock Titan
2026-03-14+7.3%earningssimplywall.stOrchestra BioMed (OBIO) First Profitable Quarter Tests Bearish Unprofitability Narrative - simplywall.st
2026-04-13+7.0%earningsMarketBeatOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
2026-03-12-6.6%earningsZacksOrchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
2026-03-12-6.6%newsGlobeNewswireOrchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
2026-03-12-6.6%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$1.11, revenue of $33.48M
2026-03-12-6.6%earningsYahoo FinanceOrchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
2025-11-10+5.8%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.40 in-line, revenue of $0.9M beats by $0.15M
2025-05-13+5.6%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.49, revenue of $0.9M
2025-05-13+5.6%newsIntellectia AIOBIO Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
2023-02-02+5.3%earningsMarketBeatOrchestra BioMed (OBIO) Stock Price, News & Analysis - MarketBeat
2023-02-02+5.3%earningsMarketBeatTop Orchestra BioMed (OBIO) Competitors 2026 - MarketBeat
2024-03-24-4.7%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2026-03-03+4.3%newsGlobeNewswireOrchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
2025-08-12+4.1%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.50, revenue of $0.84M
2026-03-11-4.0%earningsZacksCodexis (CDXS) Beats Q4 Earnings and Revenue Estimates
2023-08-11-3.8%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.35, revenue of $0.92M
2025-08-08-3.7%newsSeeking AlphaOrchestra BioMed rises as trial for antihypertensive drug expands
2026-03-13+3.4%newsThe Globe and MailOrchestra BioMed Holdings (OBIO) Receives a Buy from Chardan Capital - The Globe and Mail
2025-11-03-3.1%legalSeeking AlphaOrchestra BioMed files secondary offering of ~8M shares
2025-04-05+2.7%newsSeeking AlphaTop 10 Russell 2000 weekly gainers and losers as Wall Street crashes
2026-02-19-2.5%newsGlobeNewswireOrchestra BioMed to Participate in Upcoming Institutional Investor Conferences
2025-05-14-2.3%newsSeeking AlphaOrchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism
2025-05-14-2.3%newsIntellectia AIOBIO Forecast — Price Prediction for 2026. Should I Buy OBIO? - Intellectia AI
2025-05-14-2.3%newsSeeking AlphaOrchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism - Seeking Alpha
2023-05-12+2.3%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.40 misses by $0.12, revenue of $1.16M beats by $0.48M
2023-05-24+2.3%newsSeeking AlphaNewtekOne, Alpine Income to be added to Russell 3000; Rocket Companies to be deleted
2026-04-23-2.3%newsGlobeNewswireOrchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
2024-11-14-1.9%earningsSeeking AlphaOrchestra BioMed GAAP EPS of -$0.41, revenue of $0.99M
2022-07-06-1.8%newsSeeking AlphaOrchestra BioMed to merge with SPAC Health Sciences, collaborate with Medtronic
2023-03-16-1.4%newsSeeking AlphaOrchestra BioMed Holdings (OBIO) Investor Presentation - Slideshow
2021-09-23-1.3%newsThe Motley FoolCaribou Biosciences - CRBU - Stock Price & News - The Motley Fool
2026-01-16-1.0%analystThe Globe and MailJefferies Sticks to Its Buy Rating for Orchestra BioMed Holdings (OBIO) - The Globe and Mail
2024-03-27-0.6%newsSeeking AlphaOrchestra BioMed reports FY results
2025-05-28+0.5%expansionSeeking AlphaOrchestra BioMed: Two Best-In-Class Devices And Promising Partnerships
2026-02-13+0.3%newsGlobeNewswireOrchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-04-26—analystMSNOrchestra BioMed Holdings (OBIO) price target decreased by 11.17% to 11.39 - MSN
tickerdossier.comtickerdossier.substack.com